The solvatochromic effect of functionalized 6-aminoracil derivatives in light of DFT: FT-IR, TD-DFT, NBO, and FMO studies

被引：2

作者：

Ekici A.T. ^{[1
]}

Karakuş N. ^{[1
]}

机构：

[1] Sivas Cumhuriyet University, Science Faculty, Dep. of Chemistry, Sivas

来源：

Optik | 2024年 / 302卷

关键词：

Aminouracil; DFT; FT-IR; NBO; Solvachromic effect; TD-DFT;

D O I：

10.1016/j.ijleo.2024.171735

中图分类号：

学科分类号：

摘要：

Uracil-based compounds have increasing attention in material design for different applications as well as pharmaceutical purposes. Accordingly, the key electronic reasons underlying the solvatochromic effect and possible activity features by using quantum chemical computations should be explored in detail. This work focuses on the structural, electronic, and optical properties of the aminouracil derivatives to explore the key electronic-related properties that affect the solvatochromism features. The molecular geometries of the 1,3-dimethyl-5-(arylazo)-6-aminouracil derivatives were optimized using the DFT method at the B3LYP/6–31++G(d,p) basis set level. The solvent-phase simulations of the studied derivatives were utilized using the PCM (Polarized Continuum Model). The TD-DFT approach was employed to enlighten UV–visible characteristics such as possible electronic transitions, energies, and oscillator strengths. The NBO (Natural Bond Orbital) method was used to predict the possible intramolecular charge transfer and delocalization, as well as the interactions between donor-acceptor molecular orbitals. TD-DFT computations revealed that the bonded group within the arylazo ring would affect solvatochromic properties such as electronic excitation energies and transitions in the UV-Vis regions. The NBO analysis revealed that the electron movement from the lone pair of N atoms on the uracil unit to neighbor unfilled orbitals contributed to reducing the stabilization energy. © 2024 Elsevier GmbH

引用

共 76 条

[1] Voet D., Voet J.G., Pratt C.W., Fundamentals of biochemistry: life at the molecular level, (2016)
[2] Wang Y., Zhang X., Liu H., Zhou X., Chemical methods and advanced sequencing technologies for deciphering mRNA modifications, Chem. Soc. Rev., 50, pp. 13481-13497, (2021)
[3] Chandorkar S., Raghunathan S., Jaganade T., Priyakumar U.D., Multiscale Modeling of Wobble to Watson–Crick-Like Guanine–Uracil Tautomerization Pathways in RNA, Int. J. Mol. Sci., 22, 11, (2021)
[4] El-Kalyoubi S., Agili F., Adel I., Tantawy M.A., Novel uracil derivatives depicted potential anticancer agents: In Vitro, molecular docking, and ADME study, Arab. J. Chem., 15, 4, (2022)
[5] Myriagkou M., Papakonstantinou E., Deligiannidou G.-E., Patsilinakos A., Kontogiorgis C., Pontiki E., Novel Pyrimidine Derivatives as Antioxidant and Anticancer Agents: Design, Synthesis and Molecular Modeling Studies, Molecules, 28, (2023)
[6] Suzuki Y., Chaperone therapy for lysosomal and non-lysosomal protein misfolding diseases, Brain Dev., 45, pp. 251-259, (2023)
[7] Temirak A., Schlegel J.G., Voss J.H., Vaassen V.J., Vielmuth C., Claff T., Muller C.E., Irreversible Antagonists for the Adenosine A2B Receptor, Molecules, 27, (2022)
[8] Nayab R.S., Maddila S., Krishna M.P., Titinchi S.J.J., Thaslim B.S., Chintha V., Wudayagiri R., Nagam V., Tartte V., Chinnam S., Chamarthi N.R., In silico molecular docking and in vitro antioxidant activity studies of novel α-aminophosphonates bearing 6-amino-1,3-dimethyl uracil, J. Recept. Sig. Transd., 40, 2, pp. 166-172, (2020)
[9] Al-Tamimi M.B.W., Al-Majidi S.M.H., Synthesis, identification of some new 1,2,4-triazole derivatives from 6-amino-1,3-dimethyluracil and evaluation of their molecular docking, Anti-oxidant and experimental, Int. J. Health Sci., 6, S6, pp. 7185-7203, (2022)
[10] Alhilal M., Sulaiman Y.A.M., Alhilal S., Gomha S.M., Ouf S.A., Synthesis of Novel Acyclic Nucleoside Analogue Starting From 6-Aminouracil as Potent Antimicrobial Agent, Polycycl. Aromat. Comp., 42, 9, pp. 6463-6474, (2022)

← 1 2 3 4 5 6 7 8 →